Business Update Positive

2026-05-29 17:55

Max Healthcare reported its 22nd consecutive quarter of year-on-year growth in Q4 FY26 and full year FY26. The company successfully commissioned over 20% additional brownfield capacity and expects another 10% from its 500-bed Gurgaon greenfield hospital by FY27-end. Strategic moves include acquiring a controlling stake in Kalinga Hospital (Bhubaneswar), which is already profitable, and approving a ₹1,400 crore investment for a new 700-bed greenfield hospital in Lucknow. Management anticipates significant operating leverage as new capacities ramp up, aiming for breakeven within a year for Gurgaon. While oncology revenue mix adjusted due to discontinued drugs, other specialties are compensating, and CGHS rate revision benefits are flowing in. Net debt-to-EBITDA remains below 1.

Business Update Neutral

2026-05-28 17:15

Max Healthcare Institute's Chairman, Managing Director, and Senior Management will participate in investor conferences. They will attend Citi's 2026 India Conference on June 4, 2026, and Jefferies India Access Day 2026 on June 8-9, 2026, engaging in one-on-one and group meetings. No unpublished price sensitive information will be shared during these events.

Ownership Neutral

2026-05-24 22:32

Max Healthcare Institute Limited submitted an application to BSE and NSE on May 24, 2026, seeking approval for the re-classification of Radiant Life Care Hospital Foundation (RLCHF) from 'Promoter Group' to 'Public' category. This re-classification is in accordance with Regulation 31A of the SEBI (LODR) Regulations, 2015, following previous intimations and Board approval.

Business Update Neutral

2026-05-22 22:41

Max Healthcare Institute Limited announced that its Chairman and Managing Director will participate in the UBS Asian Investment Conference 2026 (AIC 2026) on May 27 & 28, 2026, in Hong Kong. The conference will involve physical one-on-one and group meetings. No unpublished price sensitive information will be shared during the event.

Routine Neutral

2026-05-22 22:15

Max Healthcare Institute Limited informed the exchanges on May 22, 2026, about the availability of the audio recording of the earnings call held on the same date. The call discussed the company's financial results for the quarter and financial year ended March 31, 2026. The recording can be accessed on the company's website.

Business Update Positive

2026-05-22 17:08

Max Healthcare Institute Limited announced that the Competition Commission of India (CCI) has passed orders dated May 21, 2026, closing the investigation into alleged abuse of dominant position by various Max Network hospitals. The CCI found no case of abuse of dominant position under Section 4 of the Competition Act, 2002, and the matter is closed with no adverse order, resolving a prior regulatory inquiry.

Financials Positive

2026-05-21 16:50

Max Healthcare Institute Limited reported strong Q4 FY26 consolidated financial results. Consolidated Revenue was ₹2,142.89 Cr vs ₹1,909.74 Cr (▲12.2% YoY), EBITDA was ₹606.43 Cr vs ₹511.62 Cr (▲18.5% YoY), and PAT was ₹342.22 Cr vs ₹319.00 Cr (▲7.3% YoY). EBITDA Margin expanded from 26.8% to 28.3% (▲151 bps). The board also recommended a final dividend of ₹2/- per equity share, approved the construction of a new ~712-bed Max Super Specialty Hospital in Lucknow, and re-appointed cost auditors and a Non-Executive, Non-Independent Director.

Financials Positive

2026-05-21 16:45

Max Healthcare Institute Limited reported strong Q4 FY26 consolidated financial results with Revenue from operations at ₹2,143 Cr vs ₹1,910 Cr (▲12% YoY), EBITDA at ₹606 Cr vs ₹512 Cr (▲19% YoY), and PAT at ₹342 Cr vs ₹319 Cr (▲7% YoY). EBITDA Margin expanded to 28.3% vs 26.8% (▲150bps). The board also recommended a final dividend of ₹2 per equity share and approved the construction of Phase-I of Max Super Specialty Hospital in Lucknow with ~712 census beds.

Financials Positive

2026-05-21 16:45

Consolidated Revenue from operations for Q4 FY26 was ₹2,142.89 Cr vs ₹1,909.74 Cr (▲12.2% YoY), EBITDA was ₹654.26 Cr vs ₹558.54 Cr (▲17.1% YoY), and PAT was ₹342.22 Cr vs ₹319.00 Cr (▲7.3% YoY). EBITDA Margin expanded from 29.3% to 30.5% (▲128bps). The Board recommended a final dividend of ₹2/- per equity share and approved the construction of a new Max Super Specialty Hospital in Lucknow with ~712 census beds.

Financials Positive

2026-05-21 16:41

Consolidated Revenue for Q4 FY26 was ₹2,142.89Cr vs ₹1,909.74Cr (▲12.21% YoY), EBITDA was ₹606.43Cr vs ₹511.62Cr (▲18.53% YoY), and PAT was ₹342.22Cr vs ₹319.00Cr (▲7.28% YoY). EBITDA Margin expanded to 28.30% vs 26.80% (▲150bps). The Board also recommended a final dividend of ₹2 per equity share.

Financials Positive

2026-05-21 16:40

Consolidated Revenue ₹2,142.89 Cr vs ₹1,909.74 Cr (▲12.21% YoY), EBITDA ₹478.76 Cr vs ₹413.41 Cr (▲15.81% YoY), PAT ₹342.22 Cr vs ₹319.00 Cr (▲7.28% YoY). EBITDA Margin 22.34% vs 21.65% (▲69bps). The Board also recommended a final dividend of ₹2 per equity share and approved the construction of Phase-I of Max Super Specialty Hospital, Shaheed Path, Lucknow, with a capacity for ~712 beds.

Routine Neutral

2026-05-21 16:35

New Filing detected. See link for details.

Financials Positive

2026-05-21 16:33

Network Gross Revenue ₹2,664 Cr vs ₹2,429 Cr (▲10% YoY), Network Operating EBITDA ₹682 Cr vs ₹632 Cr (▲8% YoY), Network PAT ₹387 Cr vs ₹376 Cr (▲3% YoY). EBITDA Margin 26.8% vs 27.2% (▼40bps). The company also announced acquisition of a controlling stake in Kalinga Hospital Ltd. and approval for a new 712-bed greenfield hospital in Lucknow.

Financials Positive

2026-05-21 16:29

Consolidated Revenue ₹2142.89Cr vs ₹1909.74Cr (▲12.21% YoY), EBITDA ₹606.43Cr vs ₹511.62Cr (▲18.53% YoY), PAT ₹342.22Cr vs ₹319.00Cr (▲7.28% YoY). EBITDA Margin 28.30% vs 26.79% (▲151bps). The board also recommended a final dividend of ₹2/- per equity share and approved the construction of a new ~712-bed hospital.

Governance Positive

2026-05-21 16:27

The Board of Directors approved the audited consolidated financial results for Q4 and FY ended March 31, 2026, and recommended a final dividend of ₹2/- per equity share. Other key decisions included the approval for Phase-I construction of a new 712-bed Max Super Specialty Hospital in Lucknow, the acquisition of a 58.28% stake in Kalinga Hospitals Limited for ₹297.97 Cr, and the re-appointment of Mr. Anil Kumar Bhatnagar as a Non-Executive and Non-Independent Director. The re-classification of Radiant Life Care Hospital Foundation to 'Public' category was also approved.

Governance Positive

2026-05-20 13:15

Max Healthcare Institute Limited's Nomination and Remuneration Committee approved the grant of 2,15,000 stock options to eligible employees on May 20, 2026, under the Employee Stock Option Scheme 2022. This includes 90,000 options at an exercise price of ₹350 per option and 125,000 options at ₹800 per option, with a vesting period of 1 to 5 years.

Business Update Negative

2026-05-19 22:19

CRITICAL RED FLAG DETECTED

Max Healthcare disclosed that a petition has been filed against its subsidiary, Kalinga Hospital Ltd. (KHL), before the NCLT Cuttack Bench by BRS Capital Two Pte. Limited. The petition alleges 'oppression and mismanagement' of KHL's affairs and seeks interim reliefs. The NCLT has heard submissions, reserved orders, and the next hearing is scheduled for July 7, 2026. The company cannot anticipate the outcome or its financial implications at this stage.

Business Update Positive

2026-05-18 20:20

Max Healthcare Institute Limited announced it has acquired a ~58.28% equity stake in Kalinga Hospital Ltd. (KHL) for approximately ₹297.97 Crore. KHL operates a 250-bed multi-specialty hospital in Bhubaneswar, Odisha. The acquisition was financed via a Senior Secured Term Loan of up to ₹300 Crore. KHL is now a subsidiary of Max Healthcare.

Business Update Neutral

2026-05-15 12:10

Max Healthcare Institute Limited announced an earnings call for investors and analysts on Friday, May 22, 2026, at 11:00 AM IST. The call will discuss the financial results for the quarter and financial year ended March 31, 2026. The results are scheduled to be declared on Thursday, May 21, 2026, followed by a management discussion and Q&A session during the call.

Ownership Neutral

2026-05-13 13:20

Max Healthcare Institute Limited received a request from Radiant Life Care Hospital Foundation (RLCHF) for re-classification from the 'Promoter Group' to the 'Public' category under SEBI Regulation 31A. This re-classification is due to the sale of the entire equity stake held by Mr. Abhay Soi (Promoter) and Radiant Life Care Private Limited (Promoter Group) in RLCHF. As RLCHF no longer holds any shares in Max Healthcare, this re-classification will not impact the overall shareholding of the promoter and promoter group in the company. The Board of Directors will consider the request.

Governance Neutral

2026-05-12 18:55

Max Healthcare Institute Limited announced that the resolution for the re-appointment of Mr. Narayan K. Seshadri as a Non-Executive and Non-Independent Director was duly passed via postal ballot on May 11, 2026. Out of the total votes polled, 91.07% were cast in favour of the resolution, and 8.93% were against.

Ownership Neutral

2026-05-01 19:17

Max Healthcare Institute Limited allotted 51,287 equity shares on May 1, 2026, to employees exercising vested stock options under its ESOP Scheme 2022. Each share has a face value of ₹10 and was exercised at ₹350 (including a ₹340 premium). This increased the company's paid-up equity capital from ₹973,19,25,020 to ₹973,24,37,890. The company noted this allotment is not material.

Business Update Positive

2026-04-21 22:34

Max Healthcare received a Rectification Order dated April 21, 2026, from the GST Officer, withdrawing the entire demand of ₹55.20 crore related to alleged excess Input Tax Credit, which was previously intimated on December 30, 2025.

Governance Neutral

2026-04-11 16:14

Max Healthcare Institute Limited issued a postal ballot notice seeking shareholder approval for the re-appointment of Mr. Narayan K. Seshadri as Non-Executive and Non-Independent Director for a three-year term from May 16, 2026, to May 15, 2029. E-voting will occur from April 12, 2026, to May 11, 2026, with results announced by May 13, 2026.

Routine Neutral

2026-04-08 12:23

New Filing detected. See link for details.

Routine Neutral

2026-04-08 12:22

New Filing detected. See link for details.

Routine Neutral

2026-04-08 12:20

New Filing detected. See link for details.

Routine Neutral

2026-04-08 12:18

New Filing detected. See link for details.

Routine Neutral

2026-04-07 22:17

Max Healthcare Institute Limited filed a certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026, confirming that its Registrar and Share Transfer Agent, MUFG Intime India Private Limited, received no dematerialization requests during the period.

Routine Neutral

2026-04-01 09:31

New Filing detected. See link for details.

Routine Neutral

2026-03-26 22:55

Max Healthcare Institute Limited announced the closure of its trading window for designated persons from April 1, 2026, until 48 hours after the declaration of Q4 and FY26 financial results, in compliance with SEBI Insider Trading Regulations.

Business Update Neutral

2026-03-25 22:47

Max Healthcare announced NCLT has approved the voluntary liquidation of its wholly-owned step-down subsidiary, ET Planners Private Limited, on March 25, 2026. The company stated this dissolution will not materially impact its business or financials.

Ownership Neutral

2026-03-17 10:04

On March 17, 2026, Max Healthcare Institute allotted 42,266 equity shares of ₹10 each to eligible employees under the ESOP Scheme 2022. This increased the paid-up equity capital from ₹973,09,27,750 to ₹973,13,50,410.

Business Update Positive

2026-03-17 09:55

Max Healthcare Institute Limited's Nomination and Remuneration Committee (NRC) approved the grant of 50,000 stock options at an exercise price of ₹900 per option to an eligible employee under the Employee Stock Option Scheme 2022 on March 17, 2026.

Business Update Neutral

2026-03-02 16:35

Max Healthcare's Chairman and MD will participate in the J. P. Morgan India Forum 2026 on March 9 & 10, 2026, in Singapore for one-on-one and group investor meetings. No unpublished price sensitive information will be shared.

Business Update Negative

2026-02-21 18:11

CRITICAL RED FLAG DETECTED

Max Healthcare received an appeal order from Central Tax Appeal-II, Delhi, significantly reducing the original GST, interest, and penalty demand for FY17-21. The revised demand totals approximately ₹1.78 Cr (GST ₹85.36 Lac, penalty ₹85.36 Lac, interest ₹6.89 Lac). The company plans to file a further appeal for the balance demand.

Business Update Neutral

2026-02-20 19:03

Max Healthcare Institute Limited filed an updated Investor Presentation for the 17th Kotak Chasing Growth Conference 2026, scheduled for February 23, 2026, at Grand Hyatt, Mumbai. The presentation will be used to engage with investors.

Routine Neutral

2026-02-12 22:29

New Filing detected. See link for details.

Business Update Neutral

2026-02-07 17:19

Max Healthcare will participate in investor conferences: Nuvama India Conference 2026 on February 9, 2026, and 17th Kotak Chasing Growth Conference 2026 on February 23, 2026. The company has enclosed the investor presentation to be made at these events.

Business Update Neutral

2026-02-06 22:26

Max Healthcare Institute Limited announced the audio recording of its earnings call held on February 6, 2026, for the quarter and nine months ended December 31, 2025, is available on its website.

Routine Neutral

2026-02-05 23:47

New Filing detected. See link for details.

Routine Neutral

2026-02-05 23:47

New Filing detected. See link for details.

Routine Neutral

2026-02-05 23:47

New Filing detected. See link for details.

Routine Neutral

2026-02-04 11:03

New Filing detected. See link for details.

Governance Positive

2026-02-04 10:55

On February 4, 2026, Max Healthcare Institute's Nomination and Remuneration Committee approved the grant of 2,84,520 stock options to eligible employees under the ESOP Scheme 2022. The options have exercise prices of ₹900 and ₹800 per stock option.

Routine Neutral

2026-01-29 22:23

New Filing detected. See link for details.

Business Update Neutral

2026-01-29 22:14

Max Healthcare Institute Limited announced the voluntary liquidation of MHC Global Healthcare (Nigeria) Limited, a wholly-owned non-material subsidiary. The company stated this will not materially affect its business or consolidated financials.

Financials Neutral

2026-01-28 19:18

Max Healthcare announced an earnings call for investors and analysts to discuss its Q3 & 9M FY26 financial results (quarter and nine months ended December 31, 2025). The results will be declared on February 5, 2026, and the call is scheduled for February 6, 2026, at 11:30 AM IST.

MAXHEALTH

Max Healthcare Institute Limited

Filing History

Unlock Full History